Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen

Infection and Immunity

Volumn 74, Issue 1, 2006, Pages 794-797

  Peachman, Kristina K ^a   Rao, Mangala ^a   Alving, Carl R ^a   Burge, Robert ^a   Leppla, Stephen H ^b   Rao, Venigalla B ^c   Matyas, Gary R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CATHOLIC UNIVERSITY OF AMERICA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; LETHAL TOXIN NEUTRALIZING ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT ANTHRAX PROTECTIVE ANTIGEN; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

ANTHRAX; ANTIBODY TITER; ARTICLE; BACILLUS ANTHRACIS; BACILLUS ANTHRACIS AMES; BACTERIAL SPORE; CONTROLLED STUDY; FEMALE; IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROVOCATION; RABBIT; SURVIVAL; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; FEMALE; MICE; MICE, INBRED CBA; SPORES, BACTERIAL; VACCINES, SYNTHETIC;

EID: 29644438356     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.1.794-797.2006     Document Type: Article

References (13)

1. Drysdale, M., S. Heninger, J. Hutt, Y. Chen, C. R. Lyons, and T. M. Koehler. 2005. Capsule synthesis is required for dissemination in murine inhalation anthrax. EMBO J. 24:221-227.
2. Friedlander, A. M., S. L. Welkos, and B. E. Ivins. 2002. Anthrax vaccines. Curr. Top. Microbiol. Immunol. 271:33-59.
3. Herring, D., E. Thompson, J. Hewetson, S. Little, S. Norris, and J. Pace-Templeton. 2004. Validation of the anthrax lethal toxin neutralization assay. Biologicals 32:17-27.
4. Iacono-Connors, L. C., S. L. Welkos, B. E. Ivins, and J. M. Dalrymple. 1991. Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals. Infect. Immun. 59:1961-1965.
5. Ivins, B. E., S. L. Welkos, S. F. Little, M. H. Crumrine, and G. O. Nelson. 1992. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Infect. Immun. 60:662-668.
6. Kenney, R. T., J. Yu, M. Guebre-Xabier, S. A. Frech, A. Lambert, B. A. Heller, L. R. Ellingsworth, J. E. Eyles, E. D. Williamson, and G. M. Glenn. 2004. Induction of protective immunity against lethal anthrax challenge with a patch. J. Infect. Dis. 190:774-782.
7. Little, S. F., B. E. Ivins, P. F. Fellows, M. L. M. Pitt, S. L. W. Norris, and G. P. Andrews. 2004. Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine 22:422-430.
8. Lyons, C. R., J. Lovchik, J. Hutt, M. F. Lipscomb, E. Wang, S. Heninger, L. Berliba, and K. Garrison. 2004. Murine model of pulmonary anthrax: kinetics of dissemination, histopathology, and mouse strain susceptibility. Infect. Immun. 72:4801-4809.
9. Matyas, G. R., A. M. Friedlander, G. M. Glenn, S. Little, J. Yu, and C. R. Alving. 2004. Needle-free skin patch vaccination method for anthrax. Infect. Immun. 72:1181-1183.
10. Mikszta, J. A., V. J. Sullivan, C. Dean, A. M. Waterston, A. B. Alarcon, J. P. Dekker III, J. M. Brittingham, J. Huang, C. R. Hwang, M. Ferriter, G. Jiang, K. Mar, K. U. Saikh, B. G. Stiles, C. J. Roy, R. G. Ulrich, and N. G. Harvey. 2005. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J. Infect. Dis. 191:278-288.
11. Mohamed, N., J. Li, C. S. Ferreira, S. F. Little, A. M. Friedlander, G. L. Spitalny, and L. S. Casey. 2004. Enhancement of anthrax lethal toxin cytotoxicity: a subset of monoclonal antibodies against protective antigen increases lethal toxin-mediated killing of murine macrophages. Infect. Immun. 72:3276-3283.
12. Ramirez, D. M., S. H. Leppla, R. Schneerson, and J. Shiloach. 2002. Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracis. J. Ind. Microbiol. Biotechnol. 28:232-238.
13. Welkos, S. L., T. J. Keener, and P. H. Gibbs. 1986. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51:795-800.